Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drug and Alcohol Review is Scopus-indexed (Q1, CiteScore 5), WoS SSCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Wiley-Blackwell.
Checked against the index lists dated .
ISSN 0959-5236Verify ISSN ↗1465-3362Verify ISSN ↗
Publisher: Wiley-Blackwell
Cost to publish: About US$4,430 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Health (social science) | 69 / 387 | 82nd | Q1 |
| Medicine (miscellaneous) | 117 / 466 | 75th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1989–present, best quartile Q1, CiteScore 5.
Drug and Alcohol Review is Q1 in Health (social science) (rank 69 of 387) and Q1 in Medicine (miscellaneous) (rank 117 of 466), by CiteScore 2025.
Drug and Alcohol Review is indexed in the Social Sciences Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.028, quartile Q1, with an H-index of 96.
The publisher lists an article processing charge of about US$4,430 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Drug and Alcohol Review is published by Wiley-Blackwell. Its print ISSN is 0959-5236 and its online ISSN is 1465-3362.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Social Sciences Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Drug and Alcohol Review has an h-index of 111 and a 2-year mean of 2.44 citations per paper (OpenAlex). Its Scopus CiteScore is 5, quartile Q1. On 2-year citations it ranks #70 of 378 Scopus journals in Health (social science).
Drug and Alcohol Review published 213 papers in 2025; its busiest recent year was 2023 with 219. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from Australia (47.7%), United States (11.4%) and United Kingdom (9.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.